Study in Adults to Assess the Safety and Efficacy of Inhaled IBIO123, for Post-exposure Prophylaxis of COVID-19

NCT05639166 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Immune Biosolutions Inc